AI assistant
Sending…
ORACLE CORP — Director's Dealing 2014
Mar 21, 2014
29742_dirs_2014-03-21_449360b3-4c7c-4c4e-81a6-e1f16272e733.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2014-03-21
Reporting Person: HENLEY JEFFREY (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-21 | Common Stock | M | 750000 | $10.23 | Acquired | 750000 | Direct |
| 2014-03-21 | Common Stock | S | 750000 | $38.2563 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-21 | Stock Option | $10.23 | M | 750000 | Disposed | 2014-08-27 | Common Stock (750000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1934516 | Indirect |
Footnotes
F1: Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 24, 2014.
F2: This transaction was executed in multiple trades at prices ranging from $38.00 to $38.85. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Options vest 25% annually on anniversary of grant date.
More from ORACLE CORP
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 2